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Previous studies provided evidence for
a massively increased intracellular Ca2+
concentration in red blood cells (RBCs)
of patients with end-stage renal disease
(ESRD) (Paschen et al., 1971; Gafter et al.,
1989), whereas the dialysis procedure itself
led in average to an even slightly decreased
RBC’s Ca2+ content (Paschen et al., 1971;
Długaszek et al., 2008). Based on a single
cell approach we could qualitatively con-
firm these results (Figure 1A, 2 leftmost
columns), although the extend of the Ca2+
increase was smaller compared to the cited
investigations, which is presumably caused
by differences in the methodology.
There is a good knowledge of Ca2+
related processes in RBCs (Bogdanova
et al., 2013). Additionally, an increased
intracellular free Ca2+ concentration in
RBCs has been proposed as a trigger
for intracellular aggregation (Andrews and
Low, 1999; Kaestner and Bernhardt, 2002)
as well as for endothelium-RBC adhesion
(Hebbel et al., 1980; Mohandas and Evans,
1985) and experimental evidence has been
provided (Noh et al., 2010; Steffen et al.,
2011; Borst et al., 2012; Kaestner et al.,
2012).
The molecular identity of Ca2+- and
non-selective cation channels in the RBC
membrane is steadily increasing (Kaestner,
2011) and comprise of, e.g., the CaV2.1
(Andrews et al., 2002), the TRPC6 (Foller
et al., 2008), the NMDA-receptor (Makhro
et al., 2013), and the Piezo1 (Zarychanski
et al., 2012).
The effect of erythropoietin (EPO) on
RBCs ion homeostasis is controversially
discussed. The group of Florian Lang
found an inhibition of non-selective cation
channels by EPO with a decreased number
of eryptotic RBCs if patients were treated
with EPO (Myssina et al., 2003). However,
once Ca2+ entered the RBC, EPO has
no beneficial effect toward the eryptotic
symptoms caused by Ca2+ (Vota et al.,
2013). In contrast to RBCs, hematopoi-
etic progenitor cells display an increased
cation-channel activity upon EPO expo-
sure (Cheung et al., 1997; Tong et al.,
2008). Because of its hematopoiesis stim-
ulating properties, EPO became a widely
used medication for treatment of ane-
mic patients, including chronic renal dis-
ease, hematologic disorders, and acquired
immune deficiency syndrome (Palmer
et al., 2010; Goodnough and Shander,
2013). However, several studies high-
lighted the problem of an increased risk
of thrombus formation, especially venous
thromboembolism, in patients undergo-
ing EPO therapy (Singbartl, 1994; Kliger
et al., 2012; Goodnough and Shander,
2013).
Therefore we investigated the free
Ca2+ concentration in RBCs from ESRD
(dialysis) patients under EPO treatment.
Blood samples from healthy donors, ESRD
patients and EPO treated ESRD patients
were analyzed by fluorescence live cell
imaging as previously described (Wang
et al., 2013) (Figure 1). As depicted in
Figure 1A, at rest, RBCs from ESRD
patients show higher Ca2+ concentration
compared with healthy donors, while EPO
treatment let to a slightly decreased free
internal Ca2+ concentration, indicating an
inhibition of constitutively active channels
in resting RBCs. Although the histograms
(Figure 1Ab) give an impression of the
distribution, themethod lacks quantitative
information concerning the Ca2+ concen-
tration (Kaestner et al., 2006). However,
when compared to control conditions, the
width of the distribution of Ca2+ content
is wider in ESRD patients or EPO-treated
ESRD patients, leading to the conclusion
that the cellular heterogeneity is greater
in patients than in healthy subjects. In
a further step we investigated the Ca2+
influx in RBC from healthy donors and
ESRD patients after hormonal stimula-
tion in dependence of EPO treatment
(Figure 1B). As a stimulation substance we
selected prostaglandin E2 (PGE2), which
is released from activated platelets (Smith
et al., 1973) but can also be released
from RBCs themselves when they pass
small capillaries (Oonishi et al., 1998).
The curves in Figure 1Ba present typi-
cal example traces for Ca2+ curves in
RBCs, while Figure 1Bb shows the statis-
tical analysis. Healthy patients show an
increase in Ca2+ after PGE2 stimulation
as we have previously shown (Kaestner
et al., 2004). EPO treatment prevents Ca2+
entry resulting in Ca2+ levels below con-
trol conditions confirming the results of
the Lang group (Myssina et al., 2003).
However, pretreatment with EPO even
suppressed the Ca2+ entry provoked by
PGE2. In ESRD patients, PGE2 stimulation
leads to a Ca2+ increase, which is signif-
icantly higher than in RBCs of healthy
donors. In EPO treated ESRD patients the
PGE2 induced Ca2+ increase was signif-
icantly suppressed compared to RBCs of
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FIGURE 1 | Ca2+ in RBCs of healthy donors and end-stage renal
disease (ESRD) patients with a renal anaemia. If patients were under
EPO treatment, the last EPO administration was within 5 days of blood
sampling. All experimental procedures are previously described in detail
(Wang et al., 2013). (A) Resting Ca2+ in terms of relative Fluo-4
fluorescence intensity of RBCs suspended in plasma. (Aa) Statistical
analysis of RBC Ca2+ of at least 3 individuals in each group. The white
numbers indicate the number of cells analyzed and the error bars
represent standard error of mean. (Ab) Histograms of the relative
fluorescence intensity distribution of the measurements presented in
(Aa). (B) Intracellular Ca2+-traces in RBCs under different conditions:
control (Tyrode solution containing in mM: 135NaCl, 5.4 KCl, 10 glucose,
1 MgCl2, 1.8 CaCl2 and 10 HEPES; the pH was adjusted to 7.35 using
NaOH) or stimulation with 5µM PGE2 and/or 1.5 nM EPO. (Ba) Typical
example traces of Fluo-4 fluorescence intensity over time for all
conditions tested. Traces were chosen due to their typical intensity of
response, which are analyzed in (Bb). Differences in the onset of the
response were equally distributed over a wide range for all conditions
tested (data not shown). However, it is worthwhile to mention that in
case of stimulation only a limited number of cells are responders
(Kaestner et al., 2004), which explains the difference in normalized
fluorescence intensity (F/Fo) between the example traces and the
statistical analysis of the entire cell population measured. The white
numbers indicate the number of cells analyzed. For the statistical
evaluation a Mann–Whitney test was performed and the following
convention was used: ∗∗∗p < 0.001, ∗∗p < 0.01, and ns p > 0.05.
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non-treated patients even in the putative
absence of EPO during the experiment.
The results of Figure 1 suggest that the
clinically observed thrombotic complica-
tions in patients treated with EPO seem
not to be primarily caused by an elevated
Ca2+ content of RBCs of these patients.
However, it is hypothesized that EPO
causes thrombosis as a result of inflam-
mation (Tobu et al., 2004). The elevated
basal Ca2+ level in RBCs of ESRD patients
(Paschen et al., 1971; Gafter et al., 1989;
Figure 1A) may enhance a blood clotting
once initiated by an inflammation pro-
cesses. It is a substantial finding that the
response of RBC to hormonal stimula-
tion or other treatments, like the dialysis
itself, in terms of Ca2+ entry shows a wide
variation between RBC within a popula-
tion, but also between different individuals
(Paschen et al., 1971; Wang et al., 2013;
Figure 1Ba).
In light of the above statements con-
cerning the thrombotic events and the
molecular players, the perspective of med-
ical treatment must be based on a person-
alized diagnosis followed by a personalized
medication. This applies to ESRD patients
as well as for treatments of other anemias.
Techniques and procedures allowing such
an individualized approach presumably
based on the combination of RBC popu-
lation measurements and single cell tech-
niques (Minetti et al., 2013) need urgently
to be developed.
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